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Abstract Antimicrobial resistance is a healthcare problem
of increasing significance, and there is increasing interest in
developing new tools to address bacterial infections. Bac-
teria-targeting nanoparticles hold promise to improve drug
efficacy, compliance, and safety. In addition, nanoparticles
can also be used for novel applications, such as bacterial
imaging or bioseperations. We here present the use of a
scalable block-copolymer-directed self-assembly process,
Flash NanoPrecipitation, to form zinc(II)-bis(dipicoly-
lamine) modified nanoparticles that bind to both Gram-
positive and Gram-negative bacteria with specificity. Par-
ticles have tunable surface ligand densities that change
particle avidity and binding efficacy. A variety of materials
can be encapsulated into the core of the particles, such as
optical dyes or iron oxide colloids, to produce imageable
and magnetically active bacterial targeting constructs. As a
proof-of-concept, these particles are used to bind and
separate bacteria from solution in a magnetic column.
Magnetic manipulation and separation would translate to a
platform for pathogen identification or removal. These
magnetic and targeted nanoparticles enable new methods to
address bacterial infections.
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Introduction
Bacterial infections are major contributors to morbidity and
have become increasingly difficult to manage due to the
emergence of antimicrobial resistance. There are over 2
million cases of antibiotic resistant infections in the US
each year, causing $20 billion in excess healthcare costs,
$35 billion in societal costs, 8 million additional hospital-
ization days, and 23,000 deaths annually (Centers for
Disease and Prevention 2013; World Health Organization
2015). While antimicrobial resistance rates have been
steadily rising, the development of new drugs has been
steadily decreasing. These trends provide the impetus to
develop new and improved methods to treat bacterial
infections (Holmes et al. 2016; Ventola 2015a, b; Viswa-
nathan 2014; Wisplinghoff et al. 2004).
Nanoparticles (NPs) are emerging as promising tools to
help mitigate the rise of antimicrobial resistance (Zhang
et al. 2010). NPs can encapsulate and deliver antimicro-
bials to improve drug pharmacokinetic and pharmacody-
namics profiles, ultimately resulting in improved treatment
outcomes (Peer et al. 2007; Zhang et al. 2008). Sustained
drug release formulations decrease dosing frequencies and
simplify dosing regimens, which can improve patient
compliance and subsequently reduce resistance develop-
ment rates from mismanaged drug use (Osterberg and
Blaschke 2005; Wang et al. 2011). Targeted NPs can be
especially effective at improving therapies by binding to
and accumulating at sites of infections (Singh and Lillard
2009). Targeted NP delivery elevates the local concentra-
tions of antibiotics in close proximity to bacteria, which
increases drug bacteriostatic and bactericidal activities.
Targeted delivery can also reduce off-target side-effects,
and enable or revive the use of older-generation antibiotics
that have been previously disregarded due to toxicity
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concerns (Falagas et al. 2008). In addition, targeted NPs
can be used to image or phenotype infections by delivering
imaging contrast agents (van Oosten et al. 2015).
NP targeting can be performed by modifying NP sur-
faces with functional groups that bind specifically to bac-
terial cell wall components. Targeting ligands include
vancomycin which targets peptidoglycans found on Gram-
positive bacteria, polymyxin which targets lipopolysac-
charides found on Gram-negative bacteria, or zinc(II)-
bis(dipicolylamine) (ZnDPA) which targets phos-
phatidylserine found on the surface of both Gram-positive
and Gram-negative bacteria (Choi et al. 2013; Hanshaw
and Smith 2005; Kell et al. 2008; Wong et al. 2015).
Importantly, these ligand targets are not found on the
surface of healthy mammalian cells, which allows for
specific binding and imaging of bacteria with minimal
background signals when using these targeting ligands
in vivo (Rice et al. 2015; van Oosten et al. 2013). Recent
novel uses of targeted NPs include the binding and mag-
netic separation of bacteria from solution to treat bacterial
sepsis, by passing NPs through custom-made microfluidic
devices (Lee et al. 2014). However, the use of microfuidics
for the filtering of blood may be infeasible due to he large
blood volumes and flow rates required for processing,
relative to the volumes and flow rates ammenable to
microfluidic processing. While NP targeting has been long
appreciated, and has been employed in high-priced cancer
treatments, the translation of NP-antibiotic constructs has
been hindered due to the high cost of most NP formation
processes relative to the low price of antibiotic therapies
(Bartlett et al. 2013; Piddock 2012). In addition, the use of
microfluidics for the filtering of blood may be unfeasible
due to the large blood volumes and flow rates required for
processing, relative to the volumes and flow rates permitted
in microfluidic devices. The development of new bacteria-
targeting NPs, formed by scalable NP production processes
and that can be applied in scalable methods, can help
translate new ways of combatting antibiotic resistant
infections.
Flash NanoPrecipitation (FNP) is a continuous and
scalable process for forming NPs that is ideally suited for
industrial-scale and low-cost production of targeted
encapsulated therapeutics (Johnson and Prud’homme
2003a, b; Pustulka et al. 2013; Shen et al. 2011; Weiss-
mueller et al. 2016; Zhu 2014). In this technique, thera-
peutic actives are precipitated by rapid micromixing with
an antisolvent in the presence of amphiphilic block
copolymers. Block copolymers absorb onto precipitating
actives to form sterically stabilized NPs with high drug
loads up to[75% weight. Polyethylene glycol (PEG) is
typically used as the hydrophilic section of the block-
copolymer, to form a dense brush layer on the NP surface
to confer water dispersability, resistance to opsonization,
and long circulation times in vivo. The use of PEG end-
groups modified with cell binding ligands results in NPs
decorated with targeting groups on the NP surface
(D’Addio et al. 2012, 2013). Importantly, this method
allows particles to be formed with precise fractions of NP
ligand PEG chain densities, using known blends of targeted
and non-modified block copolymers during particle for-
mation. This contrasts to the previous work that utilizes the
conventional methods of reacting targeting ligands to
functional groups on premade particles. Functionalization
of pre-made NPs presents difficulties with validation of
uniform ligand density on nanoparticle surfaces and diffi-
culties in scaleup of the conjugation reactions to com-
mercial scale. This is especially important for optimizing
cell targeting, as increasing ligand densities can improve
binding in some instances, but excessively high-ligand
densities can also result in decreased cell binding (Allen
2002; Cabral et al. 2011; Cheng et al. 2012; D’Addio et al.
2013; Elias et al. 2013; Kathleen et al. 2007; Lee et al.
2010). The FNP process enables the simultaneous encap-
sulation of several hydrophobic actives, including imaging
modalities and hydrophobic drugs, to create theranostic
NPs for novel antimicrobial treatments (Lu et al.
2015, 2016, 2017; Pansare et al. 2012, 2014). We here
present the development and characterization of FNP-
based NPs that target Gram-negative and Gram-positive
bacteria, and demonstrate proof-of-concept applications
where bacteria are separated from media using commer-
cially available and easily scalable magnetic separation
setups. The development of these FNP particles adds new
tools for managing antibiotic resistant infections.
Experimental
Materials
1.6 kDa polystyrene-block-5 kDa polyethylene glycol (PS-
b-PEG, Polymer Source Inc.), 1.8 kDa polystyrene
homopolymer (PS, Polymer Source Inc), alpha tocopherol
(VitE, Sigma-Aldrich), 6–8 kDa MWCO regenerated cel-
lulose membrane (Specra/Por, Spectrum Labs), Lennox LB
Broth (Fisher BioReagents), and magnetic MidiMACS col-
umn and separators (Miltenyi Biotec) were used as supplied.
Ettp-5 fluorophore and ZnDPAwith a carboxylic acid handle
were synthesized as previously described (Lee et al. 2014;
Pansare et al. 2014). PS-b-PEG was converted into PS-b-
PEG modified with an amine (PS-b-PEG-NH2) functional
group, and conjugated with ZnDPA via carbodiimide cou-
pling to form PS-b-PEG-ZnDPA (Supplementary methods).
Hydrophobic iron oxide (FeOA) was formed through the
oxidation of iron salts and the addition of an oleic acid coat
on iron oxide colloids (Supplementary methods).
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Nanoparticle (NP) formation and characterization
NPs with defined levels of surface ZnDPA or amine func-
tionalities were formed through Flash NanoPrecipitation
(FNP) processing as previously described (Johnson and
Prud’homme 2003a; D’Addio et al. 2013). In brief, PS, Ettp5
dye, VitE, FeOA, PS-b-PEG, PS-b-PEG-ZnDPA, and PS-b-
PEG-NH2 were dissolved at defined compositions in THF,
and rapidly micromixed with an equivalent volume of
100 mM zinc nitrate within a confined impingement jet
mixer, and diluted tenfold in a water collection bath. Parti-
cles with 0–100% ZnDPA surface functionalities were cre-
ated using defined blends of PS-b-PEG/PS-b-PEG-ZnDPA
in feed streams while keeping core-components constant. PS
was included as a nanoparticle core bulking material, and
Ettp5 was included as a fluorescent tracer and as an example
active pharmaceutical ingredient. VitE was used as a core
bulkingmaterial in particles loaded with magnetically active
FeOA due to improve miscibility between oleic acid coated
FeOA and VitE. The compositions of the particles formed
are summarized in Table S1–S3.
Particle sizes and surface properties were assessed with
dynamic light scattering analysis (Malvern Zetasizer Nano,
Malvern Instruments). Size distributions were determined
with backscattering measurements using 632 nm illumi-
nation, and displayed as intensity-weighted distributions.
Zeta distributions were measured and analyzed with the
Smoluchowski method after tenfold dilution into deionized
water.
Nanoparticle cell binding and quantification
Overnight stationary cultures of Escherichia coli (K-12
MG1655), Staphylococcus aureus (Newman), and Pseu-
domonas aeruginosa (PA14) grown in LB were diluted
100-fold in the same media, and grown to late exponential
OD600 = 1–1.2 density cultures. Late exponential growth
stage cells were inoculated with NPs by diluting nanopar-
ticles tenfold into cell cultures (*100 lg mL-1 NP con-
centration) and incubation for 30 min at room temperature.
Cells and bound NPs were harvested and separated from
unbound NPs by centrifugation at 10,000g for 1 min.
Unbound particles in media supernatant were aspirated,
and cell pellets were resuspended in fresh LB media. Cells
were washed twice, and collected for bound dye quantifi-
cation via fluorescence microscopy. To quantify the extent
of NP binding to cells, cell fluorescence was determined by
reading the EttP5 fluorescence via flow cytometry (BD
LSR-II Flow Cytometer, Becton–Dickinson) through
excitation/emission in the Alexa-700 channel. For visual
assessment of cell binding, washed cells with bound NPs
were placed on glass slides and imaged with brightfield and
fluorescence microscopy (Supplementary methods).
Magnetic separation of bacteria
Magnetic columns were decorated with ZnDPA surface-
modified FeOA NPs and utilized to separate bound cells
using a modified version of the manufacturers Miltenyi
Biotec MACS LD Column cell separation protocol. Cell
separation columnsweremagnetized through placement on a
MidiMACS Separator magnet and immobilized on a MACS
MultiStand. Columns were primed with ten column volumes
(CV) of LB, and loaded with 1.5 mg of NPs. Unbound par-
ticles were discarded and 1 mL of exponential phase E. coli
diluted to OD600 = 0.02 (*2 9 10
7 cells) was added to the
column, and unbound cells were collected. Columns were
washed with 40 CV of LB and effluent washed cells were
collected and pooled with unbound cells. Cells were serially
diluted and plated on LB-agar, whereupon colony forming
unit titers were determined after plating onto LB plates and
overnight growth. Cells were plated at the same time at the
end of each series of experiments. For serial filtration
experiments, three primed and NP loaded columns were
prepared as described above. Pooled unbound and effluent




NPs loaded with Ettp5 fluorophore were formed with
ZnDPA surface functionalization at 0, 6.3, 13, 25, 50, 75,
and 100% (i.e., percent of the PS-PEG stabilizing block
copolymer with terminal ZnDPA ligands) using FNP.
These NPs were formed by simply changing the blends of
PS-b-PEG/PS-b-PEG-ZnDPA used during NP assembly
(Fig. 1, Table S1). Particles at all surface functionalizes
exhibited similar and narrow size distributions, and all
particles had mean diameters near *120 nm (Fig. 2a, b).
Dynamic light scattering results between all formulations
attest to how the addition of ZnDPA had minimal effect on
particle size, even at maximum surface functionalization.
For example, 100% ZnDPA surface-modified NPs are
118 ± 4 nm in diameter, while unmodified NPs are
108 ± 5 nm in diameter. In addition, a linear regression
displays no observed relationship between NP size and
surface modification levels (R2\ 0.002). Thus, cell
attachment can be attributed to ligand conjugation, rather
than changes in nanoparticle size with changing ligand
modification. The small size of ZnDPA allows for the
formation of NPs with minimal impact on NP size, and is
advantageous in contrast to large targeting moieties, such
as antibodies, that cannot be grafted at the same PEG chain
modification density.
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While NP size remained similar between all modifi-
cation levels, the zeta potentials of NPs varied with
modification extent (Fig. 2c, d). Unmodified NPs have a
small zeta potential of -1.1 ± 4.3 mV, while 100%
modified NPs have a zeta potential of 16.9 ± 3.8 mV.
The increase of zeta potential with higher modification is
consistent with increased levels of ZnDPA presentation
at the NP surface, as ZnDPA would exhibit a positive
charge. Notably, the zeta potential and surface modifi-
cations are directly and linearly correlated (R2[ 0.99).
These results highlight how particles with clearly defined
and quantitative surface properties can be formed by
simply changing block copolymer compositions during
FNP. This is advantageous in how ligand conjugation
can be performed and validated prior to particle forma-
tion, in contrast to grafting-on approaches where tar-
geting moieties are conjugated onto premade NPs, and
where there may be relatively poor batch to batch uni-
formity, especially for syntheses at larger scale. Alto-
gether, NP size and zeta properties demonstrate that FNP
can be used to form NPs of comparable sizes with tun-
able surface chemistry and targeting properties.
Cell binding
To determine if ZnDPA-decorated FNP particles would
bind to bacteria, bacterial cells were incubated with
unmodified and with 50% ZnDPA-modified NPs. E. coli
and P. aeruginosa was used to model binding to Gram-
negative bacteria, and S. aureus was used to model
binding to Gram-positive bacteria. While all three cell
types appeared as off-yellow pellets when harvested
after inoculation with unmodified nanoparticles that
encapsulate green Ettp5 dye, all three cell types
appeared green after treatment with 50% ZnDPA NPs
that encapsulate Ettp5 (Fig. 3a). The E. coli and S.
aureus cell pellets were dark green colored, while that
of P. aeruginosa was lightly green colored, which
suggests differences in binding levels among the bac-
terial species. To validate that particles were binding to
bacteria, washed cells were additionally flame-fixed and
imaged on glass slides (Fig. 4, Figure S1). Bright field
images of fixed E. coli and S. aureus incubated with
either unmodified or modified bacteria show character-
istic rod or spherical shapes, respectively. Fluorescent
imaging of the same samples shows strong fluorescence
signals in samples incubated with 50% ZnDPA NPs,
while samples incubated with unmodified NPs exhibited
background levels of fluorescence. Importantly, fluo-
rescence signals are spatially co-registered with the
locations of the bacteria as determined with bright field
images, for both Gram-positive E. coli and Gram-neg-
ative S. aureus. These results attest that ZnDPA func-
tionalized particles formed with the scalable and rapid
FNP process can be utilized to bind both Gram-positive
and Gram-negative bacteria.
To study how varying NP ZnDPA surface density
affects binding, cells were incubated with NPs exhibiting
0, 6.3, 13, 25, 50, and 100% ZnDPA-modified NPs and
characterized via flow cytometry (Fig. 5). Particles below
Fig. 1 Formation of bacterial targeting nanoparticles through Flash
NanoPrecipitation. Core materials, amphiphilic block copolymers,
and ligand conjugated block copolymers are dissolved in an organic
solvent and rapidly impinged with water to initiate the precipitation of
hydrophobic core materials. Block copolymers arrest the growth of
the hydrophobic materials and form sterically stabilized nanoparti-
cles. The use of block copolymers modified with zinc(II)-bis(dipi-
colylamine) results in the formation of ligand surface functionalized
nanoparticles that bind to phosphatidylserine targets, which are found
on the surface of Gram-positive and Gram-negative bacteria
86 Appl Nanosci (2017) 7:83–93
123
25% ZnDPA modification exhibited minimal cell binding,
while particles above 25% exhibited noticeable binding.
For example, S. aureus incubated with 50% ZnDPA NPs
displayed a 33.5-fold higher mean fluorescence than those
incubated with unmodified NPs, while that of E. coli was
16.7-fold higher, and that of P. aeruginosa was 6.2-fold
higher. These results are consistent with qualitative
observations that P. aeruginosa cell pellets were less
Fig. 2 Formation of ZnDPA-modified nanoparticles. a Intensity-
weighted dynamic light scattering size distributions and b diameter
averages of particles made with various ZnDPA modifications.
c Normalized zeta potential distributions and d averages of particles
made with various ZnDPA modifications. Compositions of particles
are detailed in Table S1
Fig. 3 Image of bacteria incubated with Flash NanoPrecpitation-
based nanoparticles. Pellets of a Escherichia coli, b Pseudomonas
aeruginosa, and c Staphylococcus aureus after grown to exponential
phase and inoculation with unmodified nanoparticles encapsulating a
green Ettp5 dye (left), and inoculation with 50% ZnDPA-modified
nanoparticles encapsulating a green Ettp5 dye (right)
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Fig. 4 Microscopy images of nanoparticle-binding to bacteria.
Brightfield, fluorescence, and overlay images, respectively, of
Gram-negative Escherichia coli incubated with a–c 50% ZnDPA-
modified NPs and d–f unmodified ZnDPA NPs. Brightfield,
fluorescence, and overlay images, respectively, of Gram-positive
Staphylococcus aureus incubated with g–i 50% ZnDPA-modified NPs
and j–l unmodified ZnDPA NPs. Scale bar is 50 lm
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green than that of E. coli and S. aureus after incubation
with ZnDPA-modified NPs. The exact mechanism for
binding differences is interesting and should be investi-
gated further, but may rooted in differences between cell
membrane structure, cell morphology, or surface ligand
densities among the different cell lines tested (Brown
et al. 2015; Silhavy et al. 2010). These results also show
that sufficient ZnDPA modification is required for NP
binding to cells. Increased ZnDPA modification results in
elevated local concentrations of ligands on NP surfaces,
which can lead to increased NP avidity to cells.
To demonstrate that the ZnDPA targeting was not solely
due to its cationic charge, analogous Ettp5 encapsulated
NPs with various levels of amine functionality were made
(Figure S1). These particles also exhibit a zeta potential
that is linearly correlated with the amine modification
extent, and are positive at high modifications due to the
amine group (Figure S2). However, when 6.3, 13, 25 and
100% amine-modified NPs were incubated with E. coli, the
binding to cells was insignificant. This demonstrates the
specificity of the ZnDPA targeting moiety over simply
positively charged nanoparticles in LB media. These
results are consistent with the previous reports that ZnDPA
displays a strong nanomolar range affinity to phos-
phatidylserine ligands even in high salinity buffers,
whereas simple charge interactions can be screened due to
ionic strength (Plaunt et al. 2014).
Magnetically active NPs
One major advantage of the FNP process is the ability to
concurrently encapsulate actives in the core of NPs.
Affinity and magnetic-based separation of bacteria have
recently been identified as a potentially viable method to
treat sepsis without the use of antimicrobials (Lee et al.
2014). To assess if ZnDPA-modified NPs can be used for
analogous applications, hydrophobic Fe3O4 iron oxide
colloids were synthesized and modified with a hydrophobic
oleic acid coat such that iron oxide may be encapsulated
into the core of the particles (Supplementary methods).
When added to FNP formulation streams, stable particles
with narrow size distributions approximately *150 nm
were formed (Fig. 6a, Supplementary Table 3). The
increased size of iron oxide loaded particles over non-
loaded particles, that are *120 nm, reflects the inclusion
and sequestration of iron oxide in the particle core. Particle
ZnDPA or amine surface modification, at either 50 and
100%, did not affect particle size. Transmission electron
microscopy images of 50 and 100% modified ZnDPA NPs
with iron oxide cores reveal that the materials formed are
symmetric and spherical particles with iron colloids
homogenously dispersed in the particle core (Fig. 6b, c).
TEM images of nanoparticles without an iron oxide core
could not be imaged, due to the low electron density of
polymeric materials in comparison to iron oxide. These
results demonstrate that iron oxide colloids can be encap-
sulated into surface functionalized particles with the FNP
method.
Batch bacterial magnetic filtering
While custom-made microfluidic devices have previously
been used to magnetically filter bacteria from liquid sam-
ples, the application of customized microfluidic devices to
filter large volumes of blood in clinical settings may be
difficult to translate. To explore if FNP NPs can be used to
filter bacteria in a scalable manner, iron oxide (FeOA)
loaded NPs were incubated with E. coli as noted previously
above and passed through a commercially available Mid-
iMACS magnetic column. Cells that passed through the
Fig. 5 Fluorescence distribution of bacteria incubated with ZnDPA nanoparticles. Normalized count distribution of fluorescent a E. coli b P.
aeruginosa and c S. aureus after binding with 100, 50, 25, 13, 6.3, and 0% modified ZnDPA nanoparticles determined by flow cytometry
Appl Nanosci (2017) 7:83–93 89
123
column were collected and pooled with cells that were
washed with excess media. After *20 million cells were
incubated with 50% ZnDPA-modified FeOA NPs and
passed through the magnetic column, a total of 2.8 ± 0.1
million colony forming units were collected for a filtering
efficiency of 86%. In contrast, when cells were incubated
with unmodified FeOA NPs, 17.0 ± 4.2 million colony
forming units were formed, which is consistent with little
no bacterial filtering when unmodified particles are used.
These results demonstrate the ability to magnetically sep-
arate bacteria using ZnDPA NPs with a commercial mag-
netic separation process in a batch incubation process.
Continuous bacterial magnetic filtering
The development of a continuous and scalable method of
magnetically isolating bacteria from solution would make
bacterial separation processes easier to translate to the clinic.
This would enable a fixed-bed filtration process where the
column could be regnerated by loading and releasing NPs
from the bed.Towards this end,we investigated towhat extent
magnetic columns pre-loadedwith ZnDPA-FeOANPs can be
utilized for bacterial filtering applications. In this method, 1
mL of formed FeOA NPs was first passed through magnetic
columns and washed, whereupon *20 million E. coli cells
were subsequently filtered through the column. When
unmodified FeOA NPs were used, 25.1 ± 3.8 million CFU
were collected in theflowthrough andwashcell streams,while
17.3 ± 1.9 million CFU and 3.84 ± 1.3 million CFU were
collectedwith 50%ZnDPAand 100%ZnDPA-modifiedNPs,
respectively (Fig. 7). Although *20 million cells were
included in the column based on optical density, CFU slightly
greater than 20 million was collected, since bacteria can
continue to multiply during and after the separation process.
Under this protocol, the use of pre-packed columns containing
50%ZnDPANPs exhibits a filtering efficiency of 14%. These
results highlight that, under the conditions used, flowing cells
directly over a pre-packed column result in decreased filtering
efficiency compared to batch processes when cells are pre-
incubated with particles for prolonged periods of time and
then passed through the magnetic column. The reduction in
efficiency is consistent with kinetic and mass transfer limita-
tions that would apply to this single pass filtration process.
WhenNPmodification extents are increased to 100%ZnDPA,
the filtering efficiency is increased to 81%. This can be the
result of higher NP avidity to cells resulting in more effective
cell binding, and highlights how increasing NP modification
extents can be used to increase filtering efficacy.
Continuous filtering configurations are advantageous in
how scale up can be easily accomplished by increasing the
scale of unit operations. To investigate how increasing the
number of passes through ZnDPA NP pre-loaded columns
affects bacterial filtering efficiency, cells and cell washes
were sequentially passed through three columns, while
unbound cell count was determined between each step
(Fig. 8). After three sequential passes through columns
loaded with unmodified FeOA NPs, 25.2 ± 10 million
CFU was collected, which highlights minimal cell retention
when no cell targeting moiety is used. After three
sequential passes through 50% ZnDPA NP columns, the
filtering efficiency increased from 13% on the first pass to
42% on the third pass, while that of 100% ZnDPA NP
columns increased from 81% to 93%. This highlights that
the efficacy of bacterial removal can be increased by uti-
lizing more columns for separation processes.
Conclusion
Antimicrobial resistance is among the most pressing
problems in healthcare, and the development of new
approaches to treat bacterial infections is vital to preserve
Fig. 6 Formation of iron oxide loaded NPs. a Intensity-weighted dynamic light scattering size distributions and transmission electron
microscopy images of b 50% modified ZnDPA iron oxide NPs and c 100% modified ZnDPA iron oxide NPs. Scale bar 40 nm
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our capability to treat resistant pathogens. The develop-
ment of bacterial targeted nanoparticles may be especially
useful in improving drug efficacy, drug compliance, drug
safety, medical imaging, or even in the bioseparations of
bacteria. These constructs must be made in a scalable and
cost-effective manner for translation, however, due to the
relatively restrictive and low prices of antibiotic treat-
ments. Flash NanoPrecipitation is a scalable and continu-
ous technique of forming nanoparticles, and we here utilize
this process to form particles with highly tunable surface
properties that target both Gram-positive and Gram-nega-
tive pathogens. Importantly, this technique is a platform
technology that can be used to encapsulate a variety of core
components, such as therapeutics, diagnostic agents, or
even magnetically active materials. As a proof-of-princi-
ple, we encapsulate fluorescent tracers and utilize iron
oxide core loaded particles to bind and magnetically sep-
arate bacteria from liquid media. The bacterial separation
process is scalable and based on commercially available
setups. This work is an example of how nanoparticle-based
technologies can enable new approaches to combat
antibiotic resistant bacterial infections.
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Fig. 7 Batch magnetic separation of cells from media. a Setup of
magnetic columns and magnetic ZnDPA NPs to filter E. coli from
media. Columns are pre-loaded with particles, whereupon cells are
loaded and washed off. Effluent cells are collected and counted.
b Number of colony forming units collected after*2 9 107 cells are
passed through a column containing ZnDPA iron oxide NPs with
varying ZnDPA modification extents
Fig. 8 Serial magnetic separation of cells from media. a Setup of
serial magnetic column separation of bacteria. Columns are loaded
with particles, whereupon the first column is loaded with cells.
Effluent cells are collected and passed on through the subsequent
columns. The first column is washed and effluent cells are collected
and passed on through subsequent columns. Small volumes of cells
between each step is collected, and cells passing through effluent and
wash streams throughout each step is the number of colony forming
units that pass through the column. b Number of colony forming units
collected after *2 9 107 cells are passed through a column
containing ZnDPA iron oxide NPs with varying ZnDPA modification
extents
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